Elixinol Global

OverviewSuggest Edit

Elixinol Global is a company operating in the industrial hemp and medicinal cannabis industries. It provides hemp-derived CBD (cannabidiol) dietary supplements and food and wellness products. Elixinol Global’s businesses include Elixinol, a manufacturer and distributor of industrial hemp-based dietary supplement and skincare products, Hemp Foods, a hemp food wholesaler, retailer, manufacturer, and exporter of bulk and branded raw materials and finished product, and Nunyara.

TypePublic
Founded2017
HQHaymarket, AU
Websiteelixinolwellness.com

Latest Updates

Employees (est.) (Jun 2019)91
Revenue (FY, 2021)$9.3 M(-37%)
Share Price (Jul 2022)$0(-2%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Elixinol Global

Oliver Horn

Oliver Horn

Executive Director and Global CEO
Paul Benhaim

Paul Benhaim

Non-Executive Director
Helen Wiseman

Helen Wiseman

Chair
Beata Silber

Beata Silber

Global Head of R&D and Innovation
Rob Hasselman

Rob Hasselman

President Americas
Ron Dufficy

Ron Dufficy

Chief Financial Officer
Show more

Elixinol Global Office Locations

Elixinol Global has offices in Haymarket and Sydney
Haymarket, AU (HQ)
Level 12/680 George St
Sydney, AU
Level 5/360 Kent St
Show all (2)

Elixinol Global Financials and Metrics

Elixinol Global Revenue

Embed Graph
View revenue for all periods
Elixinol Global's revenue was reported to be $9.34 m in FY, 2021
AUD

Revenue (FY, 2021)

9.3m

Gross profit (FY, 2021)

7.3m

Gross profit margin (FY, 2021), %

78.4%

Net income (FY, 2021)

(17.0m)

EBITDA (FY, 2021)

(11.7m)

EBIT (FY, 2021)

(17.1m)

Market capitalization (22-Jul-2022)

15.5m

Closing stock price (22-Jul-2022)

0.0

Cash (31-Dec-2021)

12.6m

EV

4.8m
Elixinol Global's current market capitalization is $15.5 m.
Annual
AUDFY, 2018FY, 2019FY, 2020FY, 2021

Revenue

37.1m32.3m15.0m9.3m

Cost of goods sold

(17.2m)(15.1m)(8.3m)(4.4m)

Gross profit

20.3m17.4m7.3m7.3m

Gross profit Margin, %

55%54%48%78%
Half Year
AUDH1, 2019H1, 2020H1, 2021

Revenue

17.5m7.9m4.8m

Cost of goods sold

(9.2m)(4.9m)(2.3m)

Gross profit

8.3m3.2m2.9m

Gross profit Margin, %

47%40%60%
Annual
AUDFY, 2018FY, 2019FY, 2020FY, 2021

Cash

42.9m20.2m27.7m12.6m

Accounts Receivable

2.9m1.1m996.0k533.0k

Prepaid Expenses

3.7m6.5m1.5m1.7m

Inventories

7.0m21.3m4.7m2.2m
Half Year
AUDH1, 2019H1, 2020H1, 2021

Cash

48.1m16.8m19.0m

Accounts Receivable

4.1m1.3m1.5m

Prepaid Expenses

1.7m

Inventories

20.0m8.9m2.0m
Annual
AUDFY, 2018FY, 2019FY, 2020FY, 2021

Net Income

(860.0k)(83.1m)(104.5m)(17.0m)

Depreciation and Amortization

824.0k2.8m3.2m1.5m

Inventories

(4.5m)(25.4m)(2.2m)(244.0k)

Accounts Payable

5.3m(1.5m)(435.0k)(619.0k)
Half Year
AUDH1, 2019H1, 2020H1, 2021

Net Income

(9.8m)(90.3m)(10.8m)

Depreciation and Amortization

999.0k1.3m813.0k
AUDFY, 2018

Financial Leverage

1.1 x
Show all financial metrics

Elixinol Global Operating Metrics

H1, 2018FY, 2018H1, 2019

Countries (Customers)

404040

Facilities Owned (US), sq. ft.

20.7 k20.7 k20.7 k

Products

648888

Retailers

1 k

Elixinol Global Acquisitions / Subsidiaries

Company NameDateDeal Size
Elixinol Co. LtdNovember 02, 2018
Northern Colorado High Plains Producers LLCApril 24, 2018
Elixinol BV
Elixinol Investments Pty Ltd
Elixinol LLC
Elixinol Ltd
EXL International Holdings LLC
Hemp Foods Australia Pty Ltd
Nunyara Pty Ltd

Elixinol Global Revenue Breakdown

Embed Graph

Elixinol Global revenue breakdown by business segment: 100.0% from SALE OF NUTRACEUTICAL AND RELATED HEMP PRODUCTS

Elixinol Global revenue breakdown by geographic segment: 43.8% from AUSTRALIA, 51.2% from AMERICAS and 5.0% from EUROPE & UK

Elixinol Global Cybersecurity Score

Cybersecurity ratingPremium dataset

A

91/100

SecurityScorecard logo

Elixinol Global Online and Social Media Presence

Embed Graph

Elixinol Global News and Updates

US Cannabidiol (CBD) Market Report 2020-2024 Featuring Charlotte's Web, CV Sciences, Reliva CBD Wellness, & Elixinol Global Limited

DUBLIN, July 9, 2021 /PRNewswire/ -- The "The US Cannabidiol (CBD) Market: Size & Forecasts with Impact Analysis of COVID-19 (2020-2024 Edition)" report has been added to ResearchAndMarkets.com's offering. "The US Cannabidiol (CBD) Market: Size & Forecasts with Impact Analysis of Covid-19...

CBD-infused Cosmetics Market: COVID-19 Focused Report|Featuring Cronos Group Inc., Elixinol Global Ltd. among others|Technavio

NEW YORK, May 26, 2021 /PRNewswire/ -- The CBD-infused cosmetics market is expected to grow by USD 2.22 billion during 2020-2024, according to Technavio. The report offers a detailed analysis of the impact of the COVID-19 pandemic on the CBD-infused cosmetics market in optimistic,...

Medical Cannabis Market Size, Share 2021 Growing Rapidly at a CAGR of 25.16% with Industry Trends, Application Outlook, Revenue, and Opportunities by Elixinol Global Limited, Medical Marijuana, Extractas

TORONTO, May 25, 2021 (GLOBE NEWSWIRE) -- The latest report by Data Bridge Market Research on “Medical Cannabis Market Size, Share, Growth, Industry Trends and Forecast to 2028” offers detailed coverage of the industry and main market trends with historical and forecast market data, demand, applic…

Proactive news headlines including Nanoveu, Kingston Resources, Theta Gold Mines and Elixinol Global Ltd

Sydney, March 25, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:

CBD Consumer Health Markets, 2027 - Key Players are Elixinol Global, CV Sciences, NuLeaf Naturals, Medical Marijuana Inc, Lord Jones, Kazmira, Joy Organics, ENDOCA, and Charlotte's Web

DUBLIN, Oct. 28, 2020 /PRNewswire/ -- The "CBD Consumer Health - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering. Global CBD Consumer Health Market accounted for $7.89 billion in 2019 and is expected to reach $40.2 billion by 2027, growing at...

Elixinol Global Frequently Asked Questions

  • When was Elixinol Global founded?

    Elixinol Global was founded in 2017.

  • Who are Elixinol Global key executives?

    Elixinol Global's key executives are Oliver Horn, Paul Benhaim and Helen Wiseman.

  • How many employees does Elixinol Global have?

    Elixinol Global has 91 employees.

  • What is Elixinol Global revenue?

    Latest Elixinol Global annual revenue is $9.3 m.

  • What is Elixinol Global revenue per employee?

    Latest Elixinol Global revenue per employee is $102.6 k.

  • Who are Elixinol Global competitors?

    Competitors of Elixinol Global include Verma Farms, Goodbody Botanicals and Plant People.

  • Where is Elixinol Global headquarters?

    Elixinol Global headquarters is located at Level 12/680 George St, Haymarket.

  • Where are Elixinol Global offices?

    Elixinol Global has offices in Haymarket and Sydney.

  • How many offices does Elixinol Global have?

    Elixinol Global has 2 offices.